| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.01B | 44.66B | 50.52B | 60.25B | 51.28B | 43.03B |
| Gross Profit | 16.40B | 16.30B | 19.50B | 22.31B | 15.73B | 13.71B |
| EBITDA | 11.54B | 11.66B | 14.67B | 17.48B | 12.08B | 10.64B |
| Net Income | 4.81B | 5.03B | 7.10B | 10.17B | 7.13B | 5.96B |
Balance Sheet | ||||||
| Total Assets | 103.44B | 106.00B | 107.32B | 104.09B | 90.03B | 84.11B |
| Cash, Cash Equivalents and Short-Term Investments | 8.20B | 9.69B | 8.48B | 8.40B | 5.51B | 8.74B |
| Total Debt | 62.48B | 63.94B | 65.46B | 63.69B | 52.20B | 48.73B |
| Total Liabilities | 77.08B | 79.99B | 84.39B | 82.20B | 69.67B | 65.68B |
| Stockholders Equity | 26.30B | 25.95B | 22.84B | 21.79B | 20.26B | 18.43B |
Cash Flow | ||||||
| Free Cash Flow | 3.58B | 3.23B | 4.43B | 4.12B | 911.00M | 5.15B |
| Operating Cash Flow | 7.70B | 7.46B | 9.23B | 8.59B | 4.70B | 7.73B |
| Investing Cash Flow | -1.65B | -2.06B | -6.46B | -8.75B | -8.48B | -5.75B |
| Financing Cash Flow | -6.15B | -4.58B | -2.72B | 2.81B | 826.00M | -1.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $333.71B | 30.12 | 45.10% | 0.98% | -1.51% | -9.69% | |
73 Outperform | $155.50B | 54.83 | 18.93% | 1.34% | -11.66% | -27.80% | |
72 Outperform | $62.22B | 24.25 | 12.57% | 3.83% | -15.29% | -42.93% | |
66 Neutral | $8.30B | 10.68 | 17.36% | 1.10% | -20.09% | 121.28% | |
66 Neutral | $9.23B | 12.46 | 14.57% | 1.56% | -2.28% | -0.53% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | $13.22B | 22.56 | 6.58% | 2.67% | -18.10% | -65.24% |